New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For ACTC From The Last 14 Days
Check below for free stories on ACTC the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 27, 2014
17:15 EDTACTCAdvanced Cell Technology Announces 1 for 100 reverse stock split
Advanced Cell Technology announced that it has completed a 1:100 reverse split of its common stock. “Completing this reverse stock split is an important step in our plan to improve our corporate structure and establish ACT as a highly-regarded, publicly-traded biotechnology company. With continued progress in many of our clinical and pre-clinical programs, the Lincoln Park equity facility in place and Dr. Wotton’s arrival as CEO, this initiative is part of a larger strategy to up-list to a national stock exchange and to raise awareness and visibility with fundamental-based, institutional biotech investors,” said Ted Myles, ACT’s CFO and COO. As a result of the reverse stock split, every 100 shares of the company’s pre-reverse stock split common stock were combined and reclassified into one share of the company’s common stock. Beginning with the opening of trading on August 28, the company’s common stock will trade on the OTC Markets Group on a reverse stock split adjusted basis.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use